Gufic Biosciences informs about outcome of board meeting

05 Jun 2021 Evaluate

Gufic Biosciences has informed that the Board of Directors of the Company at its Meeting held on June 04, 2021 considered and approved the allotment of 1,91,14,506 Equity Shares of the Company of FV of Re 1 each to the Shareholders of Gufic Lifesciences ('Transferor Company' or 'GLPL') pursuant to the Scheme of Amalgamation of Gufic Lifesciences ('Transferor Company') with the Company ('Transferee Company') and their shareholders and creditors; the Audited Financial Results for the quarter and financial year ended March 31, 2021; and recommended Dividend at 10% i.e. Re 0.10 per equity share (Face Value of Re 1 each) for the financial year ended March 31, 2021, subject to the approval of the Shareholders at the ensuing Annual General Meeting.

The above information is a part of company’s filings submitted to BSE.

Gufic Biosciences Share Price

403.15 -4.70 (-1.15%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.